Orion Corporation Presented Promising Phase II Data for New Alzheimer's Disease Drug at American Academy of Neurology Annual Meeting
3/21/2013 9:49:18 AM
More...
|
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium
2/15/2013 9:00:05 AM
More...
|
Composition of the Nomination Committee of Orion Corporation
10/24/2012 8:50:44 AM
More...
|
Orion Corporation Receives Positive Phase II Study Results of a New Levodopa Product for Parkinson's Disease
10/24/2012 8:40:17 AM
More...
|
Orion Corporation Interim Report January-September 2012
10/23/2012 8:55:58 AM
More...
|
Orion Corporation, Nycomed Sign Deal for Easyhaler
8/5/2011 7:57:19 AM
More...
|
Endo Pharmaceuticals (ENDP) and Orion Corporation Begin Novel R&D Collaboration, Deal Allows the Companies to Bring Forward a Total of Eight “Discovery Phase” Candidates
1/28/2011 7:04:58 AM
More...
|
Orion Corporation Extends Contract with Medidata Solutions, Inc.
9/13/2010 12:47:15 PM
More...
|
FDA Probes Orion Corporation, Novartis Corporation (NVS) Parkinson's Drug for Possible Cancer Link
4/1/2010 6:38:41 AM
More...
|
DelSiTech Enters Into Research Collaboration With Orion Corporation
10/7/2009 9:36:00 AM
More...
|
|